In both tumour models, the combination therapy resulted in drastic tumour growth inhibition with nearly complete suppression in the strongly VEGF-dependent A673 model that persisted up to 9 days after ending treatment (as shown in Figure 3C and D; right panel, day 22). The gene discussed is VEGFA; the disease is neoplasm.